Recent Developments of Platinum-based Antitumor Drugs

Clicks: 1
ID: 310617
2024
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #390 of 409 articles by views in International Journal of Science and Social Science Research

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 409 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Even after cisplatin was approved four decades ago, platinum-based medications continue to have a leading position in cancer treatment plans. The efficacy of these medications in treating many tumour types has been proven, however their ability to treat cancers is still restricted due to the onset of severe side effects and rising drug resistance. The development of platinum (IV) prodrugs with various inhibitors has resulted from our understanding of the mechanisms of action of platinum compounds in cancer treatment. These prodrugs are being studied for their potential to reverse the effects of platinum compounds through alternative biological pathways, such as immune stimulatory mechanisms. Pt-based anti-cancer medications have advanced significantly in cancer therapy in recent years thanks to developments in chemical synthesis and nanotechnology. Numerous tactics were based on the cisplatin-like anti-cancer mechanism, and they were somewhat successful by changing existing platinum drugs. Platinum-based nano-drugs, such platinum nanoclusters, have demonstrated encouraging outcomes in clinical application and offer unique anti-cancer mechanisms. They also have significant potential in tumor-targeted therapy. This study summarises the development of Pt-based anti-cancer drug application in cancer therapy, with a focus on how to modify the drugs to increase the anti-tumor efficacy.
Reference Key
imported_1768940099_696fe2439ce68 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mominul Sinan
Journal International Journal of Science and Social Science Research
Year 2024
DOI
10.5281/zenodo.14293506
URL
https://www.ijsssr.com/j/article/view/176
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.